Ureteral Stents - Global Strategic Business Report

This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Ureteral Stents market.

Global Ureteral Stents Market - Key Trends & Drivers Summarized

Is the Rise in Urological Disorders Driving a New Era of Stent-Based Interventions?

The growing global incidence of urological disorders is significantly increasing the demand for ureteral stents, making them a critical tool in modern urological care. Ureteral stents are thin, flexible tubes inserted into the ureters to relieve obstructions, facilitate urine drainage from the kidney to the bladder, and support healing post-surgery. With the rising prevalence of conditions such as kidney stones (urolithiasis), benign prostatic hyperplasia (BPH), strictures, tumors, and post-surgical edema, the use of ureteral stents has become increasingly routine across hospitals and urology clinics. In particular, the global upsurge in lifestyle-related metabolic disorders like obesity and diabetes is linked to higher rates of stone formation, thus indirectly fueling demand for temporary or indwelling stenting procedures. As minimally invasive endourological procedures such as ureteroscopy, percutaneous nephrolithotomy (PCNL), and laparoscopic surgeries become more common, ureteral stents are increasingly utilized to ensure post-operative drainage and prevent complications. Additionally, the aging population - which is more susceptible to urinary tract dysfunction and malignancies - is expanding the patient base requiring long-term stent support. As awareness of urinary health grows and diagnostic technologies improve, more cases are being identified earlier, creating a larger pool of candidates for timely stenting interventions.

How Are Material Innovations and Patient-Centric Designs Elevating Stent Performance?

Technological advancements in stent design, materials, and coatings are significantly improving patient outcomes, tolerability, and procedural efficiency. Traditional stents made of polyurethane or silicone are being enhanced or replaced with new-generation materials that offer superior biocompatibility, flexibility, and resistance to encrustation and infection. Hydrophilic coatings, anti-microbial layers, and drug-eluting stents are gaining popularity for their ability to reduce irritation, discomfort, and risk of urinary tract infections (UTIs) - common complications associated with long-term stent use. Moreover, biodegradable stents are gaining traction as they eliminate the need for removal procedures, reducing patient burden and overall healthcare costs. These stents naturally dissolve over time, making them ideal for short-term use and post-operative recovery in stone and stricture management. In addition, manufacturers are investing in patient-friendly innovations such as stents with extraction strings, magnetic retrieval tips, and customizable lengths and shapes tailored to anatomical variability. Smart stent prototypes equipped with biosensors and wireless monitoring capabilities are in the pipeline, enabling real-time tracking of stent position, flow rates, and obstruction detection. These innovations are not only enhancing clinical efficiency but also elevating the overall patient experience, which is crucial as elective urological procedures shift toward outpatient settings and patient expectations for comfort and convenience rise.

Is Outpatient Urological Care Shaping the Next Phase of Stent Utilization?

The global shift toward outpatient care and same-day surgical procedures is playing a pivotal role in reshaping the ureteral stents market. The widespread adoption of minimally invasive urological interventions has made procedures such as stone removal and stricture dilation faster, safer, and more suitable for outpatient environments. Ureteral stents, as an essential post-procedure tool, are benefiting directly from this shift. Ambulatory surgical centers and day-care urology units are increasingly equipped to perform stent placements and removals with rapid turnaround and lower costs compared to inpatient facilities. This trend is not only boosting procedural volumes but also driving demand for easy-to-insert, pre-assembled stent kits and single-use instrumentation. Additionally, the emergence of stent tracking systems and mobile health apps is streamlining follow-up care and reducing the risk of forgotten or retained stents - a historically overlooked complication. The growing collaboration between device manufacturers and outpatient surgical networks is facilitating the design and delivery of products tailored to high-throughput, cost-sensitive environments. The movement toward outpatient urology also intersects with broader healthcare trends such as value-based care and patient-centric treatment pathways, positioning ureteral stents as both a clinical necessity and an opportunity for care optimization. This alignment between surgical innovation and patient flow management is reinforcing the role of stents as an integral part of evolving urological practice.

What Is Driving the Growth of the Global Ureteral Stents Market?

The growth in the ureteral stents market is driven by a combination of clinical demand, demographic factors, technological progress, and evolving care delivery models. One of the primary drivers is the rising global prevalence of urolithiasis and other obstructive urological conditions, which necessitate intervention using temporary or permanent stents. The widespread adoption of minimally invasive surgical techniques has further elevated the need for supportive stenting post-procedure, especially in the context of outpatient and ambulatory settings. Advances in stent design - such as drug-eluting coatings, bioabsorbable materials, and anti-reflux valves - are significantly improving device performance and reducing complication rates, making stents more appealing to both patients and providers. The aging population, particularly in developed markets, is contributing to increased volumes of chronic urinary dysfunction cases requiring long-term stenting. Improved healthcare infrastructure and awareness in emerging markets are also boosting procedural rates and device adoption. Additionally, government and private payer support for urological care - combined with innovations in supply chain and product accessibility - are accelerating market penetration. The ongoing trend of personalized medicine is pushing manufacturers to offer anatomically tailored, patient-specific solutions. As these forces converge, the ureteral stents market is poised for continued expansion, supported by the dual imperatives of clinical efficacy and improved patient quality of life.

Report Scope

The report analyzes the Ureteral Stents market, presented in terms of market value (US$ Thousand). The analysis covers the key segments and geographic regions outlined below.

Segments: Material (Metallic Ureteral Stents, Polymer Ureteral Stents); Application (Kidney Stones, Kidney Transplantation, Tumors, Urinary Incontinence, Others)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Ureteral Stents Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Ureteral Stents Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Ureteral Stents Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of players such as Allium Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 34 Featured):

• Allium Medical
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• Boston Scientific Corporation
• Coloplast
• Cook Medical
• CR Bard (a subsidiary of BD)
• EndoMed Systems
• Gohar Shafa
• Manish Medi Innovation
• Med pro Medical
• Medical Engineering Corporation
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• Olympus Corporation
• OptiMed
• Pnn Medical A/S
• Plasti-med
• Rocamed
• SILMAG

Tariff Impact Analysis: Key Insights for 2025

Global tariff negotiations across 180+ countries are reshaping supply chains, costs, and competitiveness. This report reflects the latest developments as of April 2025 and incorporates forward-looking insights into the market outlook.

The analysts continuously track trade developments worldwide, drawing insights from leading global economists and over 200 industry and policy institutions, including think tanks, trade organizations, and national economic advisory bodies. This intelligence is integrated into forecasting models to provide timely, data-driven analysis of emerging risks and opportunities.

What’s Included in This Edition:

• Tariff-adjusted market forecasts by region and segment
• Analysis of cost and supply chain implications by sourcing and trade exposure
• Strategic insights into geographic shifts

Buyers receive a free July 2025 update with:

• Finalized tariff impacts and new trade agreement effects
• Updated projections reflecting global sourcing and cost shifts
• Expanded country-specific coverage across the industry